Pallianera Pharma

Pallianera Pharma is a Canadian private biotech company focused on regenerative medicine and aesthetic products. Publicly available descriptions indicate the company has operated in orthopedics, pain management, dermatologic aesthetics, and oncology, although the clearest disclosed product focus is on musculoskeletal and cosmetic applications. Its reported pipeline includes ChondroStem, a regenerative medicine product for osteoarthritis, degenerative disc disease, and pain medicine, and Evangeline, a cosmetic biostimulator that has also been described in combination with hyaluronic acid for fine lines and wrinkles. The company appears to be very small and venture-backed, with limited public disclosure on clinical data, targets, partnerships, or commercialization progress. Based on available sources, Pallianera Pharma is best characterized as an early-stage regenerative medicine biotech rather than a commercial pharmaceutical company.